Constant continuous positive airway pressure (CPAP) is the treatment of cho
ice for the obstructive sleep apnea syndrome (OSAS). To enable the pressure
to be matched more accurately to actual requirements, and thus increase pa
tient acceptance, an autoadjusting device based on the measurement of upper
airway impedance was developed (APAP(FOT)). We investigated the efficacy a
nd compliance in continuous use at home. Fifty-two patients were treated (r
andomized crossover) with CPAP and APAP(FOT) for 6 wk each. Respiratory dis
turbances, sleep profile, and arousals improved significantly with both mod
es (AHI: baseline, 35.1 +/- 26/h; APAP(FOT), 5.0 +/- 5.2; CPAP, 4.3 +/- 6.3
; p < 0.001 baseline versus each mode). The mean pressure with APAP(FOT) wa
s significantly reduced as compared with CPAP (CPAP, 7.8 <plus/minus> 7.5 c
m H2O; APAP(FOT), 5.7 +/- 1.8 cm H2O; p < 0.001). Under APAP(FOT) the press
ure was lower than that under CPAP for 81.5 <plus/minus> 21% of the time. A
lthough overall use did not differ, 75% of the patients preferred APAP(FOT)
for home treatment. We conclude that APAP(FOT) is as efficacious as consta
nt CPAP in the treatment of OSAS. The treatment pressure can be reduced sig
nificantly, and sleep microstructure improved with APAP(FOT). These might b
e the reasons for patient preference of automatic therapy.